dihexa human clinical trials data EllieMD dihexa human trial Dihexa in

The companies that produce them aren't held to the same manufacturing standards as pharmaceutical companies because the products aren't intended to enter human bodies

Notably, these macrocyclic peptides exhibit noncompetitive behavior with either SAM or NAM, suggesting that they may function as allosteric inhibitors targeting NNMT (Van Haren et al., 2021)

If youre a tested athlete, talk to us at the consult before starting anything

The formulation combines Glycyl-L-histidyl-L-lysine copper(II) (GHK-Cu), Body Protection Compound-157 (BPC-157), Thymosin Beta-4 derivative (TB500), and the naturally occurring alpha-MSH cleavage derivative, KPV